Medicure (MCUJF) Gross Margin (2009 - 2026)
Medicure (MCUJF) recorded quarterly Gross Margin of 44.31% in Q1 2026, up 40.34% quarter-over-quarter from 31.57% in Q4 2025, and down 754.0% on a YoY basis from 6.77% in Q1 2025.
Medicure (MCUJF) Gross Margin (2009 - 2026) Analysis & Trends
Medicure's Gross Margin history runs 18 years deep, the most recent figure standing at 44.31% for Q1 2026.
- In Q1 2026, Gross Margin fell 754.0% year-over-year to 44.31%; the TTM figure through Mar 2026 stood at 39.69% (down 1580.0% YoY), while the FY2025 annual figure was 40.71%, down 1903.0% from the prior year.
- Gross Margin was 44.31% for Q1 2026 at Medicure, up from 31.57% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 73.69% in Q3 2022 to a low of 31.57% in Q4 2025.
- Historically, Gross Margin has averaged 57.46% across 5 years, with a median of 58.37% in 2024.
- The sharpest annual moves came in 2022 and 2025: Gross Margin surged 5440 bps in 2022, then slumped 2680 bps in 2025.
- A 5-year view of Gross Margin shows it stood at 69.03% in 2022, then retreated by 0 bps to 69.03% in 2023, then dropped by 15 bps to 58.37% in 2024, then slumped by 46 bps to 31.57% in 2025, then surged by 40 bps to 44.31% in 2026.
- The last three Gross Margin figures came in at 44.31% (Q1 2026), 31.57% (Q4 2025), and 33.99% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 49.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 71.66% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 82.93% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 49.50% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 98.31% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.26% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -293.83% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 65.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 61.20% |
| 10 | Medicure | - | - | 2.57 Mn | 44.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.31% |
| Dec 31, 2025 | 31.57% |
| Sep 30, 2025 | 33.99% |
| Jun 30, 2025 | 51.51% |
| Mar 31, 2025 | 51.84% |
| Dec 31, 2024 | 58.37% |
| Sep 30, 2024 | 54.32% |
| Jun 30, 2024 | 57.15% |
| Mar 31, 2024 | 68.44% |
| Dec 31, 2023 | 69.03% |
| Sep 30, 2023 | 72.77% |
| Jun 30, 2023 | 69.88% |
| Mar 31, 2023 | 67.45% |
| Dec 31, 2022 | 69.03% |
| Sep 30, 2022 | 73.69% |
| Jun 30, 2022 | 33.11% |
| Mar 31, 2022 | 70.42% |
| Sep 30, 2021 | 19.29% |
| Jun 30, 2021 | 59.75% |
| Mar 31, 2021 | 60.96% |